Cleveland Clinic Foundation v. True Health Diagnostics LLC, No. 18-1218 (Fed. Cir. Apr. 1, 2019)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

The Cleveland Clinic Foundation and Cleveland HeartLab, Inc., ( collectively, “ Cleveland Clinic ”) appeal from a decision of the United States District Court for the Eastern District of Virginia, dismissing their complaint for patent infringement under Rule 12(b)(6) and holding claim 1 of U.S. Patent 9,575,065 (the “’065 patent”) and claims 1 and 2 of U.S. Patent 9,581,597 (the “’597 patent”) invalid under 35 U.S.C. § 101 as directed to an ineligible natural law. Cleveland Clinic Foundation v. True Health Diagnos- tics LLC, No.